December 2018 Vol 9, No 12
As 2018 comes to a close, I marvel at how quickly time passes. Yet, I am simultaneously filled with a sense of pride at how much we have accomplished in this past year.
Kanako Kashima, MPH, Serena Phillips, RN, MPH, DrPH, Allison C. Harvey, MPH, Aubrey Villalobos, MPH, MEd, DrPH(c), Mandi Pratt-Chapman, MA, PhD, HON-OPN-CG
The authors discuss the efficacy of “The Fundamentals” – a competency-based online Oncology Patient Navigator Training designed by The George Washington University Cancer Center.
The authors explore how minorities affected by prostate cancer can become more informed and active in the decision-making process.
Insights into compassion fatigue, burnout, and the relevance of resilience to oncology navigators.
The PD-L1 inhibitor durvalumab showed an overall survival benefit in patients with unresectable stage III non–small cell lung cancer (NSCLC) in the phase 3 PACIFIC trial.
Immunotherapy is one of the hottest concepts in oncology care. Also called biologic therapy, this type of cancer treatment boosts the body’s own natural defenses to fight cancers.
As a navigation leader, you may want to start an oncology nurse navigation program, but you may not be sure where to start. Who do you talk to first? What message do you convey?
Observations from American Cancer Society patient navigators on programs that have gained financial support for nonclinical lay patient navigation programs.
Results 1 - 8 of 8